Research Solutions, Inc. (NASDAQ:RSSS – Get Free Report) was the recipient of a large decrease in short interest in the month of February. As of February 28th, there was short interest totalling 42,000 shares, a decrease of 62.9% from the February 13th total of 113,300 shares. Based on an average daily trading volume, of 181,000 shares, the days-to-cover ratio is presently 0.2 days. Approximately 0.1% of the company’s stock are sold short.
Research Solutions Stock Up 0.7 %
Research Solutions stock opened at $2.93 on Thursday. Research Solutions has a 12 month low of $2.38 and a 12 month high of $4.24. The company’s fifty day simple moving average is $3.59 and its 200-day simple moving average is $3.25. The stock has a market cap of $95.66 million, a P/E ratio of -19.53, a P/E/G ratio of 4.33 and a beta of 0.55.
Research Solutions (NASDAQ:RSSS – Get Free Report) last issued its earnings results on Thursday, February 13th. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.09). Research Solutions had a negative return on equity of 6.59% and a negative net margin of 8.41%. The firm had revenue of $11.91 million during the quarter, compared to analyst estimates of $11.86 million. On average, equities research analysts expect that Research Solutions will post 0.05 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Research Solutions Company Profile
Research Solutions, Inc, through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover platform that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including free basic search solutions and advanced search tools, which include the Resolute.ai and scite.ai products, a tools that allows for searching and identifying relevant research and find insights in other datasets adjacent to STM content, such as clinical trial, patent, life science and medtech regulatory information, competitor and technology landscape insights in addition to searching the customer’s internal datasets.
Further Reading
- Five stocks we like better than Research Solutions
- Conference Calls and Individual Investors
- Gold Rally vs. Oil Surge: Where Investors Are Betting Next
- The Basics of Support and Resistance
- Intel Stock Surges on New CEO – The Real Story Runs Deeper
- How Investors Can Find the Best Cheap Dividend Stocks
- Market Overreacts, But Guidewire’s Growth Story Remains Strong
Receive News & Ratings for Research Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Research Solutions and related companies with MarketBeat.com's FREE daily email newsletter.